Altria Group Inc declining smokers

What happened: U.S. adult smoking rates continue to decline, reaching all-time lows. Altria Group Inc, a major tobacco company, has been offsetting this volume loss with pricing power. However, investors are concerned about Altria's progress in non-smoking segments. Despite these challenges, Barclays raised its price target on Altria to $64, citing potential sector re-rating opportunities. Meanwhile, the cigarette smoking rate among U.S. adults dropped to another record low in 2021, with only 1 in 11 adults being current smokers.

Market impact: The declining smoking rates are negatively impacting tobacco companies like Altria, driving a shift in consumer behavior towards less harmful alternatives. This trend is pushing investors to seek out companies with strong non-smoking segments or diversified product portfolios. Altria's stock has been underweight by Barclays, reflecting these headwinds, but the recent price target increase suggests a potential re-evaluation of the company's valuation.

What to watch next: Investors should closely monitor Altria's upcoming earnings reports, particularly its growth in non-smoking segments such as heated tobacco and oral nicotine products. Additionally, the regulatory environment for alternative nicotine products will be crucial to watch, as changes could impact Altria's ability to diversify its revenue streams. Lastly, the ongoing decline in U.S. adult smoking rates will continue to shape Altria's performance, making regular updates on smoking prevalence a key metric to track.